143 related articles for article (PubMed ID: 9428385)
1. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Sauvageot J; Epstein JI
Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
[TBL] [Abstract][Full Text] [Related]
2. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
Harvey AM; Grice B; Hamilton C; Truong LD; Ro JY; Ayala AG; Zhai QJ
Arch Pathol Lab Med; 2010 Jul; 134(7):983-8. PubMed ID: 20586625
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.
Chan TY; Mikolajczyk SD; Lecksell K; Shue MJ; Rittenhouse HG; Partin AW; Epstein JI
Urology; 2003 Jul; 62(1):177-81. PubMed ID: 12837462
[TBL] [Abstract][Full Text] [Related]
7. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
[TBL] [Abstract][Full Text] [Related]
8. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE
J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575
[TBL] [Abstract][Full Text] [Related]
9. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
10. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
Oesterling JE; Chan DW; Epstein JI; Kimball AW; Bruzek DJ; Rock RC; Brendler CB; Walsh PC
J Urol; 1988 Apr; 139(4):766-72. PubMed ID: 2451037
[TBL] [Abstract][Full Text] [Related]
12. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
Epstein JI; Carmichael M; Partin AW; Walsh PC
J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792
[TBL] [Abstract][Full Text] [Related]
13. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma.
Rioux-Leclercq NC; Chan DY; Epstein JI
Urology; 2002 Oct; 60(4):666-9. PubMed ID: 12385930
[TBL] [Abstract][Full Text] [Related]
14. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy.
Straub B; Müller M; Krause H; Goessl C; Schrader M; Heicappell R; Miller K
Urology; 2001 May; 57(5):1006-11. PubMed ID: 11337316
[TBL] [Abstract][Full Text] [Related]
15. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
16. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Ellis DW; Leffers S; Davies JS; Ng AB
Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
[TBL] [Abstract][Full Text] [Related]
17. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.
Singh P; Dogra PN; Gupta NP; Nayyar R; Seth A; Javali TD; Kumar R
Indian J Cancer; 2011; 48(4):483-7. PubMed ID: 22293265
[TBL] [Abstract][Full Text] [Related]
19. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
20. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels.
Humphrey PA; Frazier HA; Vollmer RT; Paulson DF
Cancer; 1993 Mar; 71(5):1821-7. PubMed ID: 7680602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]